BUB1B and pure red-cell aplasia: In this work, we aimed to assess the frequency of carriers of germline variants in BUB1B among patients with criteria for hereditary PrCa and to clarify the biological mechanisms by which BUB1B variants might trigger carcinogenesis in human cells, as well as to evaluate their possible therapeutic implications.